Encephalitis and Encephalopathy (part 3)







Since the 1950’s, an increase in chronic disease was underway and has continued to rise rapidly ever since. We have essentially replaced self-limiting infectious diseases with chronic diseases that last a life time. Asthma, allergies, diabetes, seizure disorders, epilepsy, auto-immune diseases, sleep disorders, ADD/ADHD, dyslexia, behavioral syndromes, obesity, alcohol abuse, drug abuse, mental retardation, eating disorders, and sexual disorders are some of the chronic diseases children and adults suffer from today. Do parents or the medical community really think that trading a self-limiting disease, such as the chickenpox, for long life chronic disease is better?

What has history shown?

1. It is not surprising that the rise started in the 1950s and 1960s. Mass vaccination started after World War II, in the mid-1940s. Discussion of why “Johnny can’t readstarted in the mid-1950s, when this vaccinated generation started going to school, as did the rise in autoimmune diseases. But when this generation came to the age of 18 (1963) and entered the adult statistics, IQs started to decline, the crime rate started to rise, etc. etc.

2. The role of genetics: not everyone suffers equally from a vaccination. This tendency does run in families, however, and would seem to have a genetic component.

3. The black population and urban violence. Black children suffer from a variety of disabilities which makes them much more vulnerable to the effects of vaccination: more than 50% are out-of-wedlock births, meaning no father, an uneducated mother, no funds, no pregnancy care etc. Also more than 50% (75% ?) are premature and low birthweight (under 4-5 pounds). This also renders them highly vulnerable to the effects of vaccination.

Short-term vs. Long Term Chronic Disease

Short term, or also known as acute reactions, is also known as encephalopathy. They are usually seen as physical symptoms. These could be seen as swelling at the injection site, high fever, rash, high pitched crying or screaming (cry-encephalitis) that continues for days, breathing difficulties, fainting, sleepiness, convulsion or a seizure, or a “sudden death.” The short-term reactions can be recovered from. But all too often, the long-term effects begin to be seen. Seizures or convulsions become chronic epilepsy. Vision or hearing problems begin, or your baby or toddler suddenly becomes mute. Cerebral palsy or Autism is now questioned or evaluated.


According to Harris L. Coulter, Ph.D:


…children and adults who have been damaged by vaccination but not severely enough to be institutionalized. Their condition I have called the “post- encephalitic syndrome.”

The modern literature of psychiatry describes this condition as “conduct disorder” in young children or “sociopathic personality” in adults. These are subcategories of a larger group called “developmental disabilities,” which includes autism, dyslexia, hyperactivity, attention-span difficulties, and several dozen other conditions. The most recent edition of the Diagnostic and Statistical Manual published by the American Psychiatric Association devotes 80 pages to these disorders.

Encephalitis (whether from vaccination or from some other cause) can range from severe to moderate, even subclinical. It is also possible to have encephalitis in which the acute symptoms are extremely mild but which still does much long-term damage.

They rarely show remorse for what they have done but dissociate themselves from their acts. This may be because they sense that the impulse is outside their ability to control it — like a facial tic or a sneeze.

The “less serious” long-term sequelae resemble the more severe cases but are milder.

They have lowered resistance to infection — due, presumably, to defective operation of the immune system.

Instead of having epilepsy or seizures, the children suffer from what are called “staring spells” or “absence seizures.”

Instead of being totally deaf, they have mild loss of hearing. Or they have chronic earaches — otitis media. This is called in the United States “glue ear,” and it is a kind of buildup of water in the ear, often requiring the installation of little tubes for drainage.

Instead of being mentally retarded to the point of incapacity to function in society, they suffer loss of IQ: many function at the 80 or 90 IQ level — just above subnormality.

They are given to outbursts of rage. When combined with their tendency to impulsive behavior, this leads to many acts of impulsive violence. These individuals are frequently involved in crime, or the violence may be self- directed (suicide).

Instead of paralysis or cerebral palsy, they may lose a degree of muscular control — “atony” — especially of the hands. The parents will say that the baby doesn’t use his hands for crawling, or that he picks up objects with his feet instead of his hands.

The child will have asthma or other breathing difficulties. The incidence of asthma has been steadily rising in the United States for the past several decades — especially asthma in very small children. Children now are dying of asthma, whereas in the past doctors always used to say that “no child ever dies of asthma.”

They manifest all the cranial nerve palsies, but in a less severe form.

Another long-term effect of this vaccine is tendency to allergies, especially allergy to milk. Needless to say, a large proportion of the population in all of the industrialized countries of the world today suffer from allergies. We found that newborn infants with colic — meaning an allergy to milk– tend to react more strongly to the vaccine. Undoubtedly colic should be considered a counterindication to vaccination.

Instead of being blind, they have astigmatisms and nystagmus (involuntary and jerky repetitive movements of the eyeballs). They can be cross-eyed. They may have trouble moving their eyes from side to side. Or they are dyslexic, cannot read letters, cannot spell, cannot understand numbers, and the like. A peculiar feature is that they sometimes have obsessions about people’s eyes, are afraid to look others in the eyes, etc.

They are fascinated by fire and attracted to burning buildings and the like.

…This particular “glue ear” type of otitis was not known in American medical practice before the late 1940’s or early 1950’s — in other words, the time when the pertussis vaccine was being introduced.

Instead of being completely dumb, they may have a peculiarly harsh or dull or inexpressive voice. Often they stutter and have other speech impediments.

Migraine headaches are also very common in this population.

Another long-term effect is disturbance of sleep rhythm; the child turns night into day and day into night.

 They have sleep and appetite disturbances — anorexia and bulimia. In the latter case, they will often put on weight.

So one finds the same kinds of physical disabilities as in the more profoundly affected children, but everything is somewhat milder. “Mild” here is a relative term. After all, hyperactivity, dyslexia, and short attention span are very serious social problems — leading, in fact, to the collapse of the American educational system today.

They are often hyperactive. They have an extremely short attention span. Their behavior is dominated by impulses.

Other serious disorders are: seizures and epilepsy, blindness or loss of speech, paralysis or palsy of one or several limbs, and mental retardation. These are all possible effects of the vaccine.

…the mental, emotional, and moral dimensions of vaccine damage.

These children have a typical personality profile. They are alienated and paranoid. They have severe ego weakness — low self-esteem. They are anxious and depressed. They cannot tolerate frustration. They have an overwhelming need for control and panic when losing control of a situation. They are precociously sexual with a high level of homosexuality and bisexuality, and have tendencies to obsessive behavior, including alcoholism and drug abuse.


All of these sound familiar don’t they? What then happens to these children when they become adults?

 Harris L. Coulter, Ph.D:

…As this same generation went on into early adulthood, it created and has maintained the present historically high incidence of violent crime. Violent crime (murder, rape, aggravated assault) started to rise in the early 1960s and is still on the rise today.

At least two routes connect the post-encephalitic adolescent with alcoholism and/or drug abuse. (1) These individuals, as already noted, suffer from anxiety, depression, and low self-esteem and are thus naturally inclined to indulge in these various forms of escape. (2) There are numerous programs in U.S. schools today calling for the drug treatment of children with such conditions as hyperactivity, attention-span difficulties, and learning disabilities; approximately a million such children throughout our school systems are regularly being prescribed amphetamines and amphetamine-like drugs such as methylphenidate or pemoline for these conditions. These are addictive drugs, and it is not surprising that these children should grow up to become drug addicts.

…A large body of research has been done on the neurologic status of persons involved in violent crime. They are seen to have a very high incidence of typical post-encephalitic conditions: low IQ, hyperactivity, allergies, mental retardation, and seizure disorders.

…There is a clear relationship between the post-encephalitic syndrome and premature, exaggerated sexuality. Today we are confronted with a rise in sexually related crimes, including acts of sexual violence committed by children — as young as six or seven years of age. Accounts of these children make it clear that they suffer from other symptoms along the lines we have discussed: mental retardation, hyperactivity, learning disabilities, tendency to commit arson, and, finally, lack of remorse for their acts.

Drugs and alcohol potentiate the inherent weaknesses of the post- encephalitic personality, releasing the few inhibitions which these individuals already possess…

It would not be an exaggeration to state that the three major social problems facing the United States today: the collapse of the educational system, drug abuse, and the epidemic of violent crime are all rooted, to a considerable extent, in the prevalence of the post-encephalitic syndrome in American society. This is true for many European countries also, although to a lesser extent.


All of these above disorders of post-encephalitic syndrome were rare before the mandated vaccine programs began and history has shown this.


Harris L. Coulter, Ph.D:


“In examining the enormous literature on infectious encephalitis, I realized very quickly that the long-term effects of encephalitis is totally congruent with what we see today in the DSM3 of the American Psychological Association as “Disorders usually evident in infancy or childhood” (developmental disabilities).  That includes autism, hyperactivity, dyslexia, attention span difficulties and several dozen other conditions.”

“But no biological phenomenon is either all or nothing.  Vaccination cannot be considered to either leave a child perfectly normal or have a very severe impact on a child.  There’s got to be a range of effects-how about the children in the middle?  How about those who are slightly affected by the vaccine?  Anybody who knows anything about the biology of medicine knows that this has to be because it would be impossible to stress a large group of people, like two million babies a year in the United States and not have the reactions go along a  whole range of effects….Some of the side effects or long term affects make themselves felt not the next week or two weeks later but five or ten years later when the parent realizes that their child is not acting or behaving like other children act and tries to figure out what the reason for that is….”


“This is, at first glance, a startling omission,” says Coulter.  When the neurologic (as opposed to psychological) nature of autism was finally revealed, “mental health professionals should have immediately appreciated the tie with encephalitis.  Furthermore, it had long been known that a variety of encephalitis was caused by vaccination.  But this is precisely why physicians shied away from the topic!  Since no one wanted to impugn the [vaccination] programs, encephalitis was never discussed openly and fully.

“The Vaccine Compensation Bill of 1986 provided for the establishment of a committee under the The National Academy of Sciences Institute of Medicine to review data on vaccine damage.  This committee has published two books – one in 1989 and one in 1993 on the damage of various vaccines and they have stated in the first of these books that the evidence supports the existence of a causal relationship between the DPT vaccine and encephalitis.  That has changed the whole terms of the debate because now you can talk of vaccine damage in terms of encephalitis-that is a much more solid scientific basis.



Many of the studies found a substantial proportion of children had a physical condition such as maternal rubella, prenatal trauma, encephalitis, epilepsy or tuberous sclerosis which were all potential explanations for the autism disorders. Most of today’s children with autism were born healthy and suffered no injury or illness that could be a possible explanation.

  Different diagnostic criteria were used in the studies. Those used were:

 Kanner’s Criteria:

1) A profound lack of affective contact
2) Repetitive, ritualistic behavior which must be of an elaborate kind


   *Kanner gave some examples of behavior and did not include age of onset as essential. Kanner’s Criteria for diagnosis is the most restrictive criteria used. It mainly focuses on the most severe forms of autism and does not allow for milder cases of autism found in Asperger’s Syndrome and PDDNOS (Pervasive Developmental Disorder Not Otherwise Specified). Some studies, however, that used Kanner’s criteria allowed for “atypical” autism cases to be counted, or those that did not fully fit the picture of Kanner’s criteria.


Rutter’s Criteria:

1) Impaired social development which has a number of special characteristics out of keeping with the child’s intellectual level
2) Delayed and deviant language development that also has certain defined features and is out of keeping with the child’s intellectual level
3) “Insistence on sameness” as shown by stereotyped play patterns, abnormal preoccupations or resistance to change
4) Onset before 30 months


   *Rutter gave many examples of behavior. Rutter’s Criteria for diagnosis is broader than Kanner’s and allows for more children to be diagnosed, but whom still fit more typical or classic autism patterns. Milder cases of the Autism Spectrum would still not fit the criteria.


DSM-III Criteria

1) Lack of responsiveness to others
2) Language absence or abnormalities
3) Resistance to change or attachment to objects
4) The absence of schizophrenic features
5) Onset before 30 months


   *DSM-III also had categories for childhood onset (after 30 months and before 12 years) and for atypical pervasive developmental disorder (PDD).


   *The DSM-III criteria for diagnosis was far broader than any previous criteria. It recognized that autism could occur in any level of severity and now included the symptoms of Asperger’s Syndrome, although it did not directly name the disorder. Passive acceptance of social approaches and one-sided approaches were now included as social impairment. The criteria allowed for more milder cases of autism to be counted.


DSM-III Revised criteria:

1) Impairment in reciprocal social interaction (at least 2 from 5 items, comprising of specified clinical examples)
2) Impairment in verbal and nonverbal communication (at least 1 of 6 items)
3. Markedly restricted repertoire of activities and interests (at least 1 of 5 items)
4. A grand total of at least 8 from among the 16 items listed.


   *This shift included children with the most subtle symptoms. The DSM-III Revised criteria for diagnosis was the broadest criteria to exist to date. The DSM-III had been revised because many doctors believed the DSM-III was too restrictive and did not allow for children who were clearly autistic to be diagnosed because of varying symptoms and histories. But, many doctors felt that the DSM-III Revised edition was too broad and would include children who did not have autism to fit the criteria. The various subtypes of the spectrum were put into a single category of PDDNOS.


Criteria used in one Japanese study:

1) Disturbed interpersonal relationships (defined by a list of clinical examples comprising of 9 items)
2) Absence or deviance in speech and language development (8 items).
3) Insistence on the preservation of sameness or resistance to change (6 items).
4. Abnormal responses to sensory stimuli or motility disturbance (10 items).


   *The criteria used in this one study is a mix of new and old criteria used in other studies. Numbers 2 and 3 are similar to criteria used in other studies, but the broadness of number 1 is different than others and number 4 is the only criteria that included sensory and motor disturbances.


Today’s criteria, DSM-IV:

   DSM-IV, which is used today, continued the broader conception of the DSM-III, yet attempted to rein back on its DSM-III Revised edition by combining the two, but also restricting the criteria so that it would not catch those who did not have an autistic disorder. It achieved this by improving its specificity as well as separating the subtypes of autism.



   In 1966, Victor Lotter published the first study of the prevalence of autism in Middlesex, an English county in Britain.


   He searched for children with typical autism between the ages of 8 and 10 who were born between 1953 and 1955 as described by Kanner. He used a screening schedule for teachers in all schools and case notes reviewed for children in special schools as his method. He found 35 children out of 77,800 with a rate of 4.5 children per 10,000 (1 per 2222). Of those who fit typical autism, 2 per 10,000 (1 per 5,000) were found and a rate of 2.5 per 10,000 (1 per 4,000) were found with atypical autism.


   Classification of typical autism or atypical autism depended on how closely the clinical picture fitted the clinical criteria. Almost all had some degree of mental retardation and some had other conditions suggesting brain dysfunction. He also found that girls diagnosed as autistic tend to be more severely mentally retarded than the autistic boys. A substantial proportion of children had a physical condition such as maternal rubella, prenatal trauma, encephalitis, epilepsy or tuberous sclerosis. The rates given were below the mean rate tabulated.



Classic and everyday children’s illnesses in practice

Post-vaccinal encephalitis (PVE)

1. Post-vaccinal encephalitis (PVE)

The Prague pathologist Prof. Lucksch coined this phrase in 1924 and described, in a number of scientific studies, brain damage following inoculations where the children were all over the age of three.  Austrian professors Kaiser and Zappert adopted Prof. Lucksch’s designation in an investigation carried out on 240 children, 237 of whom were older than three at the time of vaccination.

2. (Bland) post-vaccinal encephalopathy

The Dutch pathologist de Vries demonstrated that, up to the age of three, a child cannot react to damage caused by inoculation with an inflammatory defensive reaction of the brain! A baby’s brain merely reacts to post-vaccinal damage with cerebral oedema and unformed blood constituents escaping from the blood vessels as an expression of disruption of the blood-brain-barrier.

Unlike encephalopathy, encephalitis is an easily identifiable clinical picture. Consequently post-vaccinal damage was identified in Austria, yet not in Germany and it is becoming apparent why there were seemingly fewer post-vaccinal reactions in Germany than in Austria.

Lucksch, Kaiser and Zappert were unable to make a distinction between the above terms as, in Austria and northern Bohemia, inoculations were carried out at a much later stage than was the case in Germany.

3. Post-vaccinal reactions / post-vaccinal complications / post-vaccinal damage

As defined by the German Federal Epidemics Law, post-vaccinal damage is health damage which extends beyond the usual extent of a post-vaccinal reaction and is generally permanent. This damage must become apparent within a certain period after inoculation and is known as “standardized incubation period.” An incubation period of between three days and three weeks is given for PVE and post-vaccinal encephalopathy with acute symptoms of disorientation and even unconsciousness, fever extending beyond the tenth day after inoculation, convulsive attacks either generalised or accentuated on one side, limb pal[TEXT INCOMPLETE IN ORIGINAL SOURCE.] occasionally isolated cranial nerve p[TEXT INCOMPLETE IN ORIGINAL SOURCE.] rare cases meningism.

In addition, however, developments with fewer symptoms are described, known as bland post-vaccinal encephalopathy. The symptoms here are abnormal behaviour such as drowsiness, loss of interest, refusal to eat, vomiting, arrested development with loss of previously acquired faculties, progressive cerebral organic disorders.

Sticker (1908) and Petov (1930) were able to prove beyond doubt firstly, that hayfever occurred far more frequently among the privileged classes of town dwellers than in the rural population where pollen was more prevalent. Secondly, they described initial manifestation following revaccination beginning in the person’s early twenties, i.e. following the second vaccination against smallpox conducted in accordance with the German Reich’s Vaccination Law.

In 1962 Professor Herrlich pointed out that post-vaccinal encephalopathy required a certain period of illness before anatomopathological changes developed in the central nervous system and yet these were barely identifiable externally. He named the main symptoms as hypersomnia with disrupted day-night rhythm, apathy, unmotivated shrill crying, therapy-resistant convulsive attacks.

Without doubt there is an enormous spread to the effect that most children tolerate vaccinations apparently without problems and others suffer severe brain damage with debility, paralysis or epilepsy.

So it becomes apparent that, in the acute stage, encephalopathy is hard to identify, yet produces delayed damage to a large extent. Late sequelae are all the more severe, the younger the child is at the time of injury. Post-vaccinal damage is not generally immediately obvious. The possibility of damage is usually only considered weeks, months or even years later as there are virtually no characteristic medical features to indicate whether the child’s symptoms are the result of vaccination or not. This generally applies to all vaccinations.

Basically there is only one definite hallmark of a post-vaccinal reaction, so-called “arrested development” following inoculation. If a child has developed normally and unimpaired up to a certain time and fairly soon after an inoculation remains at a certain stage or regresses and develops abnormal behaviour, then it can be assumed that the vaccination is the cause.

It is extremely difficult to identify this in infancy where points of development are fluid and where timing cannot be precisely determined; even if it has been admitted by official quarters that post-vaccinal damage may involve few symptoms.

Typical post-vaccinal reactions here are: agitation, tendency to take fright, irritability, uncertain movements and reactions, dazed state even apathy, eating disorders, disturbed sleep, fever, cutaneous reactions, headaches, twitching limbs, convulsive attacks, etc.

French and American studies (e.g. by Dr. Abeltier, Dr. Calmar and Prof. Delore) described changes in emotional state and character in the context of post-vaccinal damage with behavioural disorders such as lack of concentration, impaired learning faculties, aggressiveness, hyperactivity, reduced inhibitory threshold and much more.

Syndromes connected with post-vaccinal reactions:

1. Minimal Cerebral Dysfunction (MCD)

An abundance of detailed material, particularly related to the DPT vaccine, has been available in the USA since 1948 following a study in Pediatrics by Byers and Moll. Following a dramatic cluster of SID syndrome connected with decades of vaccination and reports to the FDA and CDC health authorities (the latter operates a system for monitoring disease following vaccination, the MSIFI), the whooping cough component was withdrawn for the time being, resulting in a marked drop in SID syndrome.

This is a collective term for changes in small children which are difficult to diagnose and which have been described with increasing frequency since the fifties. The frequency with which medical reports are received from countries where vaccination is carried out very early and on a particularly large proportion of children, such as the USA, France, the Netherlands and Germany, is striking.

The most frequent sign of a possible case of hard-to-identify minimal encephalopathy, in children of average intelligence and normal functional capacity, is severe distractibility with inability to focus attention and exaggerated coordinated movements. If the inducement is significantly increased, the child’s emotional state is frail and their staying-power minimal, particularly as regards their memory and ability to learn as they are characterized by extreme restlessness.

The symptoms also extend to delays in speech development. In Germany the number of children who learn to talk very late and have difficulties forming proper sentences is estimated at between 18 and 34%.

In the USA the number of children with learning difficulties increased by over 30% between 1958 and 1980. This increase is debated in connection with three decades of whooping cough vaccination as the number of children with congenital alexia rose by leaps and bounds in a staggered manner.

2. Hyperkinetic syndrome (HKS) or Psycho-organic syndrome (POS)

This describes behavioural disorders which extend beyond those so far mentioned, characterised by hyperactive and uncontrolled behaviour, increased aggressiveness, reduced inhibitory threshold and significant loss of concentration. Instead of “fidgety Phil” here we have “problem children” who are treated with methods based on educational psychology and, in extreme cases, are prescribed psychopharmaceuticals with all the associated risks for their later emotional behaviour and physical activity. The number of children under 12 taking psychopharmaceuticals is around 1.4 million.

3. Autism

4. Allergic diseases

“Autistic syndrome,” first described in 1943 by the American child psychiatrist Kanner, is characterized by disrupted intellectual and speech development, extreme isolation from their surroundings and an anxious, obsessive need to maintain the status quo in their material environment (fear of change).

The condition is suspected to be a consequence of post-vaccinal encephalopathy which was not identified, especially as the cause is known as “infantile cerebral organic damage” in conventional medicine…

Recent decades have witnessed an increase in this group of disorders which is expected to continue further.

Professor Herrlich was the first to point out this connection in the Handbuch der Schutzimp-fungen [Handbook of prophylactic vaccinations]. Later it was the Prenzlau diabetologist Dr. Schneider (1973 and 1975) and also Prof. Stuck 1993 in Padiatrische Praxis [Paediatric practice], volume 1 with the article: “Mumpsimpfung und Auftreten eines Diabetes mellitus Typ la” [Mumps inoculation and the occurrence of Diabetes mellitus type la], in which he described 19 cases connected with mumps vaccination.

In addition to food allergies, allergic asthma and neurodermatitis, hayfever is above all the disease perhaps most associated with infantile inoculation.

Pollen may perhaps be the external cause of this syndrome yet the organism’s immunological sensitivity is the more fundamental process whereby, to appreciate Louis Pasteur’s epidemiology, the underlying principle should be: “Germs are nothing–it is the territory which is important.”

Interestingly, the first reports of hayfever came from England, only a few years after Edward Jenner incorporated foreign protein into the human body.

If today one child in four suffers from some form of allergy, the question must be asked as to whether the process of sensitizing with foreign protein represents not just immune training but possibly also leaves behind a confused “allergic” immune system.

While at that time only two vaccinations were given (at age 2 and 12), from the sixties onwards early multiple inoculations were carried out accompanied by the parallel geographical and sociological occurrence of epidemic hayfever in infants.

5. Immunodeficiency

6. Diabetes mellitus

The increase in children with lowered resistance from the recurrent infections described above, childhood diseases experienced retoxically, multiple bouts of a childhood disease, otitis or tonsillitis as toxic foci and the increase in bacterial and viral resistance.

So far twelve cases of infantile diabetes have been reported in the literature connected with prophylactic inoculation against smallpox.

7. Multiple sclerosis / facial paresis / Bechterew’s disease

Articles 51 and 52 of the German Federal Epidemics Act make statutory provision for a condition to be recognized as “compensable post-vaccinal damage” and a hardship clause is included for disease where evidence of probability cannot be produced, as medical science is undecided as to the cause of the diagnosed condition. This so-called “authorization” was created by the legislator, aware that certain diseases may be provoked by external influences. We talk here of a “trigger mechanism.”

Since viruses, acting as “trigger mechanisms,” are capable of setting the start of these diseases in motion, it is just as possible that vaccines containing viruses or viral constituents can have the same effect.

MS and facial paresis are named in the Federal Epidemics Act and it is pointed out in “Anhaltspunkten fur arztliche Gutachtertatigkeit im sozia-len Entschadigungsrecht und nach dem Schwerbe-hindertengesetz, Ausgabe 1983 [Grounds for expert medical involvement in social compensation law and under the Severely Disabled Act, Edition 1983]” in point 139 “Assessing causality” that Bechterew’s disease also falls under Art. 52, Para. 2.

8. Sudden infant death (SID) syndrome (cot death)

Virtually all infectious diseases have been declining regularly and almost uniformly for decades, yet the so-far unexplained phenomenon of cot death has been increasing continuously, albeit with a slight regression in the last ten years. In 1965 the Leipzig pathologist P. F. Mahnke published his study: “Plotzlicher Tod im Kindesalter und vor-ausgegangene Schutzimpfungen” [Sudden death in childhood and previous prophylactic vaccinations]. The Paul Ehrlich Institute (PEI) published the following statement in numerous medical journals in October 1992: “The PEI is calling for cases to be reported. Death from unknown cause in babies and infants following prophylactic vaccination. The PEI is interested to learn whether deaths of babies and infants from unknown causes have been observed in Germany in the past 12 months, especially following prophylactic vaccination.”


*Note, the Back to Sleep Campaign was initiated in 1994. The DTaP vaccine was licensed in 1996 and recommended for routine use, and a year later replaced DTP vaccines in most medical offices.  Yet:

… despite our best efforts to date, SIDS remains the leading cause of death for infants one month to one year of age, claiming the lives of approximately 2,000 babies in the U.S. each year.  Even more alarming is the fact that African American and Native American babies continue to be at 2-3 times greater risk than Caucasian babies….” (See history #3 above)

The SIDS rate has declined but was it due to the Back to Sleep Campaign or the discontinued use of DTP vaccine shortly after?

October 31, 2008 Pediatrics Study:

Health Risk Behaviors in Adolescents With Chronic Conditions

RESULTS. Youth with a chronic condition were more likely to smoke daily, to be current cannabis users, and to have performed violent or antisocial acts. Youth with a chronic condition were also more likely to report 3 or 4 risk behaviors.

CONCLUSIONS. These results indicate that having a chronic condition carries additional risks for engaging in health risk behaviors and emphasize the importance of health risk screening and preventive counseling for young people in general and among those suffering from chronic conditions in particular.

Encephalitis and Encephalopathy (part 1)


headVaccines containing Pertussis and Measles can cause encephalitis. Per the VICP guidelines; onset of encephalitis from Pertussis-containing vaccines is 24-48 hours, and between day five and fifteen for the MMR, M, MR and R vaccines.  
This is what the Vaccine Injury Compensation Program stated in the late 1980’s: 
The neurologic signs and symptoms of encephalopathy may be temporary with complete recovery or may result in various degrees of permanent impairment.  
Signs and symptoms such as high-pitched and unusual screaming, persistent inconsolable crying, and bulging fontanel are compatible with an encephalopathy, but in and of themselves are not conclusive evidence of encephalopathy. Encephalopathy usually can be documented by slow wave activity on an electroencephalogram. 
Today it states: 
The following clinical features alone, or in combination, do not demonstrate an acute encephalopathy or a significant change in either mental status or level of consciousness as described above: Sleepiness, irritability (fussiness), high-pitched and unusual screaming, persistent inconsolable crying, and bulging fontanelle. Seizures in themselves are not sufficient to constitute a diagnosis of encephalopathy. In the absence of other evidence of an acute encephalopathy, seizures shall not be viewed as the first symptom or manifestation of the onset of an acute encephalopathy.  



*This means it is no longer considered a contradiction to further vaccination.

An adverse reaction association does have a name and it is called: Crying Syndrome or Screaming Syndrome.  The scream is also known as cry-encephalitis. The cause is infection of the brain from the vaccine virus/bacteria. When the body is injected with virus/bacteria it can travel to the brain and cause encephalitis. Encephalitis can be a reaction to any vaccine but the DTP and DTaP is the most common.

What is interesting to note is that when encephalitis occurs following an illness, a doctor will treat it correctly. However, following a vaccination, a doctor will tell you it is a normal reaction to the vaccine and do nothing.


Workshop on neurologic complications of pertussis and pertussis vaccination

A multidisciplinary workshop held from September 29 to October 1, 1989, at Airlie House, Warrenton, Virginia, considered the neurologic complications of whooping cough and pertussis vaccine. Pertussis mortality in the U.S. in 2-3/1000 cases. Seizures occur in 1.9% of cases, and encephalopathy in 0.3%. Reviewing all data, it appears likely that a combination of one or more bacterial toxins, asphyxia, CO2 retention and loss of cerebral vascular autoregulation is responsible for neurologic symptoms. The timing of the encephalopathy suggests that it results from increased lysis of bacteria, and release of endotoxin. The encephalopathy is not confined to the paroxysmal phase. In evaluating side-reactions to the vaccine, the following must be kept in mind: 1. Vaccines are not standardized between manufacturers. 2. For a given manufacturer, vaccines are not standard from one batch to the next. 3. Unless the vaccine is properly prepared and refrigerated, its potency and reactivity varies with shelf life. In fact, the whole question of vaccine detoxification has never been systematically investigated. Listed in order of increasing severity, observed adverse reactions include irritability, persistent, unusually high pitched crying, somnolence, seizures, a shock-like “hypotensive, hyporesponsive” state, and an encephalopathy. Since the neurologic picture is not specific for pertussis vaccination, its temporal relationship to the vaccination is the critical variable for determining causation. Although the majority of seizures following pertussis vaccination are associated with fever, it was the consensus of the neurologists attending the workshop, that these do not represent febrile convulsions, but are non-benign convulsions. The incidence of post-vaccine encephalopathy is difficult to ascertain.


 Basically, the screaming is caused by the pain of the endotoxin in the vaccine getting into his brain. The screaming then causes a release of cortisol through the body which disrupts the immune system. It also causes the body temperature to rise. The intestines ph or acidity of changes, and bacteria called e-coli increases. If the amount gets high, that is when it can cause problems. The DTP is known to slow the function of the liver but it is not known which babies will be affected. Therefore, it becomes important to neutralize the curlin and take strain off the liver.


According to Drugs.com:


Diphtheria / Tetanus Toxoids / Acellular Pertussis Vaccine

( DTaP/Tdap ) Pronouncation: (diff-THEER-ee-uh/TET-ah-nus/ay-SELL-yoo-ler per-TUSS-uss vaccine) Class: Toxoid


Trade Names: 

Active booster immunization against diphtheria, tetanus, and pertussis as a single dose in persons 11 to 64 yr of age.
– Injection 2 Lf units diphtheria toxoid, 5 Lf units tetanus toxoid, 3 mcg pertactin, 5 mcg filamentous hemagglutinin (FHA), 2.5 mcg detoxified pertussis toxins, 5 mcg fimbriae types 2 and 3 per mL.


Active booster immunization against diphtheria, tetanus, and pertussis as a single dose in persons 10 to 18 yr of age.
– Injection 2.5 Lf units diphtheria toxoid, 5 Lf units tetanus toxoid, 2.5 mcg pertactin, 8 mcg FHA, 8 mcg inactivated pertussis toxins per 0.5 mL
– Injection 15 Lf units diphtheria toxoid, 5 Lf units tetanus toxoid, 10 mcg pertussis toxoid, 5 mcg FHA, 3 mcg pertactin, 5 mcg fimbriae types 2 and 3 per 0.5 mL


– Injection 25 Lf units diphtheria, 10 Lf units tetanus toxoid, 25 mcg pertussis toxin, 25 mcg FHA, 8 mcg pertactin per 0.5 mL


– Injection 6.7 Lf units diphtheria toxoid, 5 Lf units tetanus toxoid, 46.8 mcg pertussis antigens (approximately 23.4 mcg each of inactivated pertussis toxin and FHA) per 0.5 mL

Daptacel , Infanrix , Tripedia (DTaP)

Active immunization against diphtheria, tetanus, and pertussis in infants and children 6 wk to 6 yr of age (prior to seventh birthday).


Per CDC, Tdap is for use in adults and children 10 yr of age and older, and DTaP is for use in infants and children younger than 7 yr of age.


Encephalopathy within 7 days of previous administration of DTP, Tdap, or DTaP that is not attributable to another cause; progressive neurologic disorders (eg, infantile spasms, uncontrolled epilepsy, progressive encephalopathy), in addition, pertussis vaccine should not be administered to persons with these conditions until a treatment regimen has been established and condition has stabilized; hypersensitivity to any component of the vaccine; history of serious allergic reaction temporarily associated with a previous dose of vaccine or any component of the vaccine.


Daptacel , Infanrix , Tripedia

Use in adults or children 7 yr of age and older; if contraindication to pertussis vaccine component occurs, substitute diphtheria and tetanus toxoids for pediatric use (DT) for each remaining dose; defer elective immunization procedures during outbreak of poliomyelitis because of risk of provoking paralysis.


It is recommended that the same brand of DTaP ( Daptacel , Infanrix , Tripedia ) be given for all doses in the immunization series because no data exist on the interchangeability of DTaP vaccines. Tdap vaccines ( Adacel , Boostrix ) are not interchangeable with DTaP vaccines.




Give DTaP/Tdap with caution to patients on anticoagulant therapy.



May reduce vaccine’s efficacy.

 Influenza vaccine

To attribute causality of adverse reactions, do not give influenza vaccine within 3 days of pertussis vaccination.

Laboratory Test Interactions

None well documented.


Adverse Reactions



Myocarditis (postmarketing).


Cyanosis (postmarketing).


Cyanosis (postmarketing).



Headache (44%); tiredness (30%); hyposthesia, paresthesia, vasovagal syncope (postmarketing).



Headache (43%); fatigue (37%); convulsion, encephalitis, facial palsy, paresthesia (postmarketing).



Fussines (76%); fretfulness (40%); drowsiness (33%); anorexia (11%); convulsions, febrile convulsion, grand mal convulsion, hypotonia, hypotonic-hyporesponsive episode, partial seizures, somnolence, screaming (postmarketing).



Drowsiness (38%); anorexia (12%); fussiness (9%); convulsions, crying, encephalopathy, hypotonia, hypotonic-hyporesponsive episode, irritability, somnolence (postmarketing).



Drowsiness (29%); irritability (25%); anorexia (10%); fussiness (6%); autism, convulsion, encephalopathy, grand mal convulsion, hypotonia, neuropathy, somnolence (postmarketing).



Rash (3%); pruritus, urticaria (postmarketing).



Exanthem, Henoch-Schonlein purpura, rash (postmarketing).


Erythema, pruritus, rash, urticaria (postmarketing).



Nausea (13%); diarrhea (10%); vomiting (5%).


GI symptoms including abdominal pain, diarrhea, nausea, vomiting (26%).


Vomiting (7%); diarrhea, nausea (postmarketing).


Vomiting (7%); diarrhea, intussusception (postmarketing).


Vomiting (5%).



Lymph node swelling (7%).



Lymphadenitis, lymphadenopathy (postmarketing).



Idiopathic thrombocytopenic purpura, lymphadenopathy, thrombocytopenia (postmarketing).



Idiopathic thrombocytopenic purpura (postmarketing).



Anaphylactic reaction, arthus-type hypersensitivity.



Allergic reaction, anaphylactic reaction (edema, face edema, face swelling, generalized rash and other types of rash, pruritus), hypersensitivity (postmarketing).



Anaphylactic reaction, hypersensitivity (postmarketing).



Anaphylactic reaction (postmarketing).



Pain (78%); erythema (25%); swelling (21%); injection-site bruising, sterile abscess




Pain (75%); redness (48%); swelling (39%); increase in arm circumference (28%); induration, inflammation, local reaction, mass, nodule, warmth (postmarketing).



Tenderness (50%); increased arm circumference (30%); redness (17%); swelling (12%); cellulitis, injection-site abscess, injection-site mass, injection-site nodule, injection-site pain, injection-site rash.



Redness (59%); swelling (50%); pain (27%); injection-site reactions (postmarketing).



Redness (33%); swelling (28%); pain (21%).



Body ache or muscle weakness (30%); sore and swollen joints (11%); muscle spasms, myelitis, myositis (postmarketing).



Arthralgia, back pain, myalgia (postmarketing).



Limb swelling (postmarketing).



Chills (15%); fever (5%).



Fever (14%); insulin-dependent diabetes mellitus (postmarketing).



Crying (59%); decreased activity (51%); fever (24%).



Fever (7%); cellulitis, ear pain, respiratory tract infection, sudden infant death syndrome (postmarketing).



Fever (25%); apnea, sudden infant death syndrome (postmarketing).



Category C .





Safety and efficacy not established in children younger than 11 yr of age.


Not indicated for use in patients younger than 10 yr of age or older than 18 yr of age.


Daptacel , Infanrix , Tripedia

Safety and efficacy in infants younger than 6 wk of age not established; contraindicated for persons 7 yr of age and older.



Safety and efficacy not established in individuals 65 yr of age and older.

Special Risk Patients

If any of the following occurs in temporal relation with receipt of either whole-cell pertussis DTP or DTaP, carefully consider decision to administer subsequent doses of vaccine containing pertussis component: temperature of at least 105°F within 48 h not caused by another identifiable cause; collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 h; persistent inconsolable crying lasting at least 3 h occurring within 48 h; or convulsions, with or without fever, occurring within 3 days. If the decision is made to withhold pertussis component, continue immunization with DT (Td if 7 yr of age and older). If Guillain-Barré syndrome occurs within 6 wk of receipt of prior vaccine containing tetanus toxoids, base decision to give subsequent doses of DTaP or any vaccine containing tetanus toxoids on potential benefits versus risks. Patients who experience serious Arthus-type hypersensitivity reactions following a prior dose of tetanus toxoids usually have high serum tetanus antitoxin levels and should not be given Td or DTaP vaccines or even emergency doses of Td more frequently than every 10 yr, even if wound is neither clean nor minor.

Bleeding disorders

Use with caution in patients with bleeding disorders (eg, thrombocytopenia, hemophilia) or receiving anticoagulant therapy.

Convulsions/CNS disorders

Family history of seizures or other CNS disorders is not a contraindication to pertussis vaccine.

Febrile illness or acute infection

Defer immunization during course of illness. Minor respiratory illness, such as mild upper respiratory tract infection, is usually not a reason to defer immunization.


May have diminished antibody response; defer immunization, if possible, until immunocompetency is restored.

Latex sensitivity

Stoppers for Daptacel and Tripedia vials, and tip cap and rubber plunger of Infanrix and Boostrix needleless prefilled syringes contain dry natural latex rubber that may cause allergic reactions in latex-sensitive individuals.


Measles, Mumps, and Rubella (MMR) vaccine

Brand Names: M-M-R II


What should I discuss with my healthcare provider before receiving this vaccine?

You should not receive this vaccine if you are allergic to:

  • eggs;
  • gelatin;
  • neomycin (Mycifradin, Neo-Fradin, Neo-Tab); or
  • if you have ever had a life-threatening allergic reaction to any vaccine containing measles, mumps, or rubella.

You should also not receive this vaccine if you have:

  • a chronic disease such as asthma or other breathing disorder, diabetes, kidney disease, or blood cell disorders such as anemia;
  • severe immune suppression caused by disease (such as cancer, HIV, or AIDS), or by receiving certain medicines such as steroids, chemotherapy or radiation; or
  • if you are pregnant.

Before receiving this vaccine, tell the doctor if you have:

  • thrombocytopenia purpura (easy bruising or bleeding);
  • active tuberculosis infection;
  • a history of seizures;
  • a neurologic disorder or disease affecting the brain (or if this was a reaction to a previous vaccine);
  • a weak immune system caused by disease, bone marrow transplant, or by using certain medicines or receiving cancer treatments;
  • if you have received an immune globulin or other blood product within the past year; or
  • if you have received a previous MMR vaccine within the past 28 days (4 weeks).

You can still receive a vaccine if you have a cold or fever. In the case of a more severe illness with a fever or any type of infection, wait until you get better before receiving this vaccine.

You should not receive a measles, mumps, and rubella vaccine if you are pregnant. Wait until after your child is born to receive the vaccine.

Avoid becoming pregnant for at least 3 months after receiving a measles, mumps, and rubella vaccine.

Do no not receive this vaccine without telling your doctor if you are breast-feeding a baby.

What should I avoid before or after receiving this vaccine?

Do not receive another “live” vaccine such as oral polio, yellow fever, or varicella (chickenpox) for at least 4 weeks after you have received the measles, mumps, and rubella vaccine. The other live vaccine may not work as well during this time, and may not fully protect you from disease.

Measles, mumps, and rubella vaccines side effects

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot. Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.

Becoming infected with measles, mumps, or rubella is much more dangerous to your health than receiving the vaccine to protect against these diseases. Like any medicine, this vaccine can cause side effects, but the risk of serious side effects is extremely low.


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

  • problems with hearing or vision;
  • extreme drowsiness, fainting;
  • easy bruising or bleeding, unusual weakness;
  • seizure (black-out or convulsions); or
  • high fever (within a few hours or a few days after the vaccine).

Less serious side effects include:

  • redness, pain, swelling, or a lump where the shot was given;
  • headache, dizziness;
  • low fever;
  • joint or muscle pain; or
  • nausea, vomiting, diarrhea.

Side effects other than those listed here may also occur. Contact your doctor about any side effect that seems unusual or that is especially bothersome.

What other drugs will affect measles, mumps, and rubella vaccine?

Before receiving this vaccine, tell the doctor about all other vaccines you have recently received.

Also tell the doctor if you have recently received drugs or treatments that can weaken the immune system, including:

  • an oral, nasal, inhaled, or injectable steroid medicine;
  • medications to treat psoriasis, rheumatoid arthritis, or other autoimmune disorders, such as azathioprine (Imuran), efalizumab (Raptiva), etanercept (Enbrel), leflunomide (Arava), and others; or
  • medicines to treat or prevent organ transplant rejection, such as basiliximab (Simulect), cyclosporine (Sandimmune, Neoral, Gengraf), muromonab-CD3 (Orthoclone), mycophenolate mofetil (CellCept), sirolimus (Rapamune), or tacrolimus (Prograf).

If you are using any of these medications, you may not be able to receive the vaccine, or may need to wait until the other treatments are finished.

There may be other drugs that can affect this vaccine. Tell your doctor about all the prescription and over-the-counter medications you have received. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.


ProQuad -Measles, Mumps, Rubella, and Varicella Vaccine

Do NOT use ProQuad if:

  • you are allergic to any ingredient in ProQuad , including gelatin
  • you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to neomycin
  • you have a weakened immune system (eg, advanced HIV, AIDS, decreased gamma globulin levels, decreased white blood cell levels), blood problems, cancer affecting the blood or bone marrow (eg, leukemia), fever, or active or untreated tuberculosis (TB)
  • you are pregnant
  • you are taking an immunosuppressant (eg, cyclosporine) or a salicylate (eg, aspirin)

Contact your doctor or health care provider right away if any of these apply to you.

Before using ProQuad :

Some medical conditions may interact with ProQuad . Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

  • if you are planning to become pregnant or are breast-feeding
  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if you have allergies to medicines, foods, or other substances
  • if you are allergic to eggs
  • if you have an infection, a tumor, HIV, low blood platelet levels, a history of seizures or head injury, or a family history of seizures or immune system weakness
  • if you have had a recent blood or plasma transfusion or have received immune globulin or a tuberculin test
  • if you have been exposed to measles, mumps, rubella, or chickenpox
  • if you have a history of tuberculosis

Some MEDICINES MAY INTERACT with ProQuad . Tell your health care provider if you are taking any other medicines, especially any of the following:

  • Corticosteroids (eg, prednisone) or immunosuppressants (eg, cyclosporine) because the effectiveness of ProQuad may be decreased
  • Salicylates (eg, aspirin) because the risk of side effects may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if ProQuad may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

Important safety information:

  • ProQuad may cause drowsiness or dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to ProQuad . Using ProQuad alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.
  • This medicine may decrease the effectiveness of tuberculin tests. If you are scheduled to have a tuberculin test within 6 weeks after receiving this vaccination, contact your doctor. You may need to reschedule your tuberculin test.
  • Avoid contact with individuals with weakened immune systems, pregnant women who have not had chickenpox, and newborns whose mothers have not had chickenpox for 6 weeks after receiving this vaccination.
  • Avoid use of salicylates (eg, aspirin) for 6 weeks after receiving this vaccination.
  • Keep written documentation of all vaccinations received to help avoid unnecessary doses. Be sure that your doctor knows the dates that you have received other vaccinations.
  • This vaccine may not guarantee protection against measles, mumps, rubella, or chickenpox. Discuss any questions or concerns with your doctor.
  • Adult women may experience joint pain 2 to 4 weeks after receiving this injection. This usually lasts only a short time. However, these symptoms have persisted for months or, rarely, years.
  • ProQuad contains albumin, which comes from human blood. There is an extremely rare risk of developing a viral disease, or a central nervous system disease called Creutzfeldt-Jakob disease. No cases of viral diseases or Creutzfeldt-Jakob disease from albumin have been identified.
  • Use ProQuad with extreme caution in CHILDREN younger than 12 months of age. Safety and effectiveness in this age group have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: Do not use ProQuad if you are pregnant. If you suspect that you could be pregnant, contact your doctor immediately. After receiving ProQuad , do not become pregnant for at least 3 months without checking with your doctor. It is unknown if ProQuad is excreted in breast milk. Do not breast-feed while using ProQuad .

Possible side effects of ProQuad :

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; dizziness; fever; general unwell feeling; headache; irritability; mild rash; muscle or joint ache or pain; nausea; pain, tenderness, soreness, or swelling at the injection site; tiredness; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fainting; loss of coordination; mental or mood changes; numbness or tingling in the fingers or toes; red, swollen, blistered, or peeling skin; seizures; unusual bruising or bleeding; vision or hearing changes.

This is not a complete list of all side effects that may occur. If you have questions or need medical advice about side effects, contact your doctor or health care provider. You may report side effects to the FDA at 1-800-FDA-1088 (1-800-332-1088) or at http://www.fda.gov/medwatch.


Encephalitis and Encephalopathy



Encephalitis is inflammation of the brain. The inflammation is caused either by an infection invading the brain (infectious); or through the immune system attacking the brain in error (post-infectious / autoimmune encephalitis).

Encephalitis is different from meningitis. Meningitis means inflammation of the protective layers that cover the brain. Sometimes patients have both meningitis and encephalitis and this is called meningoencephalitis.


Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Encephalopathy may be caused by infectious agent (bacteria, virus, or prion), metabolic or mitochondrial dysfunction, brain tumor or increased pressure in the skull, prolonged exposure to toxic elements (including solvents, drugs, radiation, paints, industrial chemicals, and certain metals), chronic progressive trauma, poor nutrition, or lack of oxygen or blood flow to the brain. The hallmark of encephalopathy is an altered mental state. Depending on the type and severity of encephalopathy, common neurological symptoms are progressive loss of memory and cognitive ability, subtle personality changes, inability to concentrate, lethargy, and progressive loss of consciousness. Other neurological symptoms may include myoclonus (involuntary twitching of a muscle or group of muscles), nystagmus (rapid, involuntary eye movement), tremor, muscle atrophy and weakness, dementia, seizures, and loss of ability to swallow or speak. Blood tests, spinal fluid examination, imaging studies, electroencephalograms, and similar diagnostic studies may be used to differentiate the various causes of encephalopathy.



  Pertussis vaccination and epilepsy–an erratic history, new research and the mismatch between science and social policy.


For over 50 years, concerns have been raised about the risk of pertussis vaccine-induced childhood encephalopathy and epilepsy. This article reviews the scientific literature, and the social and historical context in which the scientific, public health and societal views have not always been aligned. Large-scale studies of this issue have produced conflicting results, although the recent consensus is that the risk of vaccine-induced encephalopathy and/or epilepsy, if it exists at all, is extremely low. Risk estimates in the literature have included: risk of a febrile seizure 1 per 19,496 vaccinations; risk of an afebrile seizure 1 per 76,133 vaccinations; risk of encephalopathy after pertussis infection nil-3 cases per million vaccinations. A recent study showed that encephalopathy in 11 out of the 14 children studied, although previously attributed to vaccination, was in fact due an inherited genetic defect of the SCNIA gene that codes for the voltage gated neuronal sodium channel. This study is important because it provides a solid alternative explanation for the perceived pertussis vaccine-encephalopathy association. The interesting possibility is raised that the encephalopathy apparently due to pertussis itself may, in some cases, be due to an SCNIA mutation. It may also, by analogy, shed some light on the continuing debate about other serious long-term adverse effects of vaccination in general.


 To be continued…the autism connection, post-vaccinal encephalomyelitis, the rise in neurological disorders…